Study of a localized meningococcal meningitis epidemic in Burkina Faso: Incidence, carriage, and immunity

Journal of Infectious Diseases

Volumn 204, Issue 11, 2011, Pages 1787-1795

  Mueller, Judith E ^a,g   Yaro, Seydou ^b   Njanpop Lafourcade, Berthe Marie ^a   Drabo, Aly ^b   Idohou, Régina S ^a   Kroman, Sita S ^a   Sanou, Oumarou ^a   Diagbouga, Serge ^b,h   Traoré, Yves ^c   Sangaré, Lassana ^d   Borrow, Raymond ^e,f   Gessner, Bradford D ^a  

^a Agence de Medecine Preventive   (France)

^b Centre Muraz   (France)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g EHESP SCHOOL OF PUBLIC HEALTH   (France)

^h Centre National de la Recherche Scientifique et Technologique   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BABY RABBIT COMPLEMENT ANTIBODY; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATION; BURKINA FASO; CEREBROSPINAL FLUID CULTURE; CHILD; COMMUNITY; DISEASE SURVEILLANCE; EPIDEMIC MENINGITIS; FEMALE; FLU LIKE SYNDROME; GENDER; GEOGRAPHY; HEALTH CENTER; HUMAN; INCIDENCE; INFANT; KITCHEN; KITCHEN SMOKE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MASS IMMUNIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEASON; SEROPREVALENCE; SERUM BACTERICIDAL ANTIBODY ASSAY; SMOKE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; BURKINA FASO; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COOKING; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP A; PREVALENCE; SMOKE; VACCINATION; YOUNG ADULT;

EID: 80155207355     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir623     Document Type: Article

References (25)

1. Lapeyssonnie L. La méningite cérébrospinale en Afrique. Bull World Health Organ 1963; 28(suppl):1-114.
2. Sié A, Pfluger V, Coulibaly B, et al. ST-2859 serogroup A meningococcal meningitis outbreak in Nouna health district, Burkina Faso: A prospective study. Trop Med Int Health 2008; 13:861-8.
3. World Health Organization. Launch of meningococcal A conjugate vaccine, Burkina Faso, December 2010. http://www.who.int/immunization/ newsroom/events/menafrivac/en/index.html. Accessed 28 January 2011.
4. Parent du Chǎtelet I, Traore Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: Surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 2005; 40:17-25.
5. Mei Z, Grummer-Strawn LM, de Onis M, Yip R. The development of aMUAC-for-height reference, including a comparison to other nutritional status screening indicators. Bull World Health Organ 1997; 75:333-41.
6. Mueller JE, Sangaré L, Njanpop-Lafourcade BM, et al. Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. Emerg Infect Dis 2007; 13:847-54.
7. Maslanka SE, Gheesling LL, LiButti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin Diagn Lab Immunol 1997; 4:156-67.
8. World Health Organization. Managing meningitis epidemics in Africa. WHO/HSE/GAR/ERI/2010.4. http://whqlibdoc.who.int/hq/2010/ WHO-HSE-GAR-ERI-2010. 4-eng.pdf. Published November 2010. Accessed 7 March 2011.
9. Rose AM, Mueller JE, Gerstl S, et al. Meningitis dipstick rapid test: Evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS One 2010; 5:e11086.
10. Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006; 43:817-22.
11. Njanpop-Lafourcade BM, Mounkoro D, Drabo, et al. Characterization and antibiotic susceptibility of invasive and carriage meningococci in Burkina Faso in 2006 and 2008. Poster presented at: International Pathogenic Neisseria Conference; 11-16 September 2010; Banff, AB, Canada; abstract P051.
12. Mueller JE, Yaro S, Traoré Y, et al. Neisseria meningitidis serogroup W135 and A: carriage and immunity in Burkina Faso, 2003. J Infect Dis 2006; 193:812-20.
13. Kristiansen PA, Diomandé F, Wei SC, et al. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol 2011; 18:435-43.
14. Mueller JE, Gessner BD. A hypothetical model for meningococcal meningitis in the African meningitis belt. Int J Infect Dis 2010; 15:e553-9.
15. Mueller JE, Yaro S, Madec Y, et al. Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso. Trop Med Int Health 2008; 13:1543-52.
16. Hodgson A, Smith T, Gagneux S, et al. Risk factors for meningococcal meningitis in northern Ghana. Trans R Soc Trop Med Hyg 2001; 95:477-80.
17. Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity serologic correlates of protection for evaluating the response to meningococcal vaccines. Clin Vaccine Immunol 2010; 17:840-7.
18. Sjölinder H, Jonsson AB. Olfactory nerveda novel invasion route of Neisseria meningitides to reach the meninges. PLoS One 2010; 5:e14034.
19. Daum RS, Sood SK, Osterholm MT, et al. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period. J Pediatr 1989; 114:742-7.
20. Marchant CD, Band E, Froeschle JE, McVerry PH. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine. Pediatr Infect Dis J 1989; 8:508-11.
21. Madore DV, Johnson-Kraines CL, Rothstein EP, Smith DH. Kinetics of antibody responses to Haemophilus influenzae type b vaccines. Curr Med Res Opin 1999; 15:105-12.
22. Dellicour S, Greenwood B. Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci. Trop Med Internat Health 2007; 12:1409-21.
23. Mueller JE, Borrow R, Gessner BD. Meningococcal serogroup W135 in the African meningitis belt: Epidemiology, immunity and vaccines. Expert Rev Vaccines 2006; 5:319-36.
24. Boisier P, Nicolas P, Djibo S, et al. Meningococcal meningitis: Unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis 2007; 44:657-63.
25. Delrieu I, Yaro S, Tamekloé TAS, et al. Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE. 2011;6:e19513.